Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 15 for:    stargardt's macular dystrophy
Previous Study | Return to List | Next Study

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Ocata Therapeutics
Sponsor:
Information provided by (Responsible Party):
Ocata Therapeutics
ClinicalTrials.gov Identifier:
NCT01345006
First received: April 28, 2011
Last updated: November 3, 2014
Last verified: November 2014